CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS)
Product revenue	$ 345.9	$ 305.6	$ 664.8	$ 617.9
Service revenue	67.1	63.5	130.4	124.2
Other revenue	1.9	2.6	4.6	5.0
Total revenue	414.9	371.7	799.8	747.1
Cost of product revenue	192.6	162.3	365.3	332.5
Cost of service revenue	38.7	38.0	74.4	75.4
Cost of other revenue	0.2	1.3	0.3	2.3
Total cost of revenue	231.5	201.6	440.0	410.2
Gross profit	183.4	170.1	359.8	336.9
Operating expenses:
Selling, general and administrative	102.8	100.9	200.9	193.6
Research and development	40.7	36.8	78.3	72.9
Other charges, net	6.4	12.0	9.5	16.0
Total operating expenses	149.9	149.7	288.7	282.5
Operating income	33.5	20.4	71.1	54.4
Interest and other expense, net	(3.3)	(2.6)	(9.3)	(8.2)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	30.2	17.8	61.8	46.2
Income tax provision	6.2	3.0	16.1	7.8
Consolidated net income	24.0	14.8	45.7	38.4
Net income attributable to noncontrolling interest in consolidated subsidiaries	0.6	0.3	0.7	0.3
Net income attributable to Bruker Corporation	$ 23.4	$ 14.5	$ 45.0	$ 38.1
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.15	$ 0.09	$ 0.28	$ 0.23
Diluted (in dollars per share)	$ 0.15	$ 0.09	$ 0.28	$ 0.23
Weighted average common shares outstanding:
Basic (in shares)	159.5	161.4	159.6	162.3
Diluted (in shares)	160.4	162.4	160.4	163.3
Comprehensive income (loss)	$ 71.6	$ (2.2)	$ 109.1	$ 54.0
Less: Comprehensive income attributable to noncontrolling interests	1.0	0.1	1.2	0.3
Comprehensive income (loss) attributable to Bruker Corporation	$ 70.6	$ (2.3)	$ 107.9	$ 53.7
Dividend declared (in dollars per share)	$ 0.04	$ 0.04	$ 0.08	$ 0.08